Patrick James Orme

Array ( [id] => 7599703 [patent_doc_number] => 07582744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Chemically modified oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/200703 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 59414 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582744.pdf [firstpage_image] =>[orig_patent_app_number] => 11200703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205615 [patent_doc_number] => 20070027097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Small interfering RNA with improved activity' [patent_app_type] => utility [patent_app_number] => 11/192354 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8228 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027097.pdf [firstpage_image] =>[orig_patent_app_number] => 11192354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636086 [patent_doc_number] => 20100035793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Modulators' [patent_app_type] => utility [patent_app_number] => 11/989244 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14669 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035793.pdf [firstpage_image] =>[orig_patent_app_number] => 11989244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769163 [patent_doc_number] => 20060019924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Novel mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 11/186807 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16441 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019924.pdf [firstpage_image] =>[orig_patent_app_number] => 11186807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590802 [patent_doc_number] => 20060040253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Use of Smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney' [patent_app_type] => utility [patent_app_number] => 11/183194 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 40353 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040253.pdf [firstpage_image] =>[orig_patent_app_number] => 11183194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125486 [patent_doc_number] => 20070237757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Compositions and Methods for Inhibiting the Synthesis or Expression of Mmp-1' [patent_app_type] => utility [patent_app_number] => 11/628829 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12563 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237757.pdf [firstpage_image] =>[orig_patent_app_number] => 11628829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904515 [patent_doc_number] => 20080113929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist' [patent_app_type] => utility [patent_app_number] => 11/629106 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26485 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113929.pdf [firstpage_image] =>[orig_patent_app_number] => 11629106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813854 [patent_doc_number] => 20080194485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Detection and Use of Prolylcarboxypeptidase' [patent_app_type] => utility [patent_app_number] => 11/597676 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23148 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194485.pdf [firstpage_image] =>[orig_patent_app_number] => 11597676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978528 [patent_doc_number] => 20050288246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Peptide conjugated, inosine-substituted antisense oligomer compound and method' [patent_app_type] => utility [patent_app_number] => 11/136245 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10805 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288246.pdf [firstpage_image] =>[orig_patent_app_number] => 11136245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672942 [patent_doc_number] => 20060178297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Systems and methods for silencing expression of a gene in a cell and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/136344 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17464 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178297.pdf [firstpage_image] =>[orig_patent_app_number] => 11136344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873226 [patent_doc_number] => 20080199960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Methods for the Delivery of Oligomeric Compounds' [patent_app_type] => utility [patent_app_number] => 11/596238 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 33401 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199960.pdf [firstpage_image] =>[orig_patent_app_number] => 11596238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978526 [patent_doc_number] => 20050288244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Oligonucleotides comprising a C5-modified pyrimidine' [patent_app_type] => utility [patent_app_number] => 11/119533 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 49528 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288244.pdf [firstpage_image] =>[orig_patent_app_number] => 11119533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7595447 [patent_doc_number] => 07626014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety' [patent_app_type] => utility [patent_app_number] => 11/115989 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 59468 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/626/07626014.pdf [firstpage_image] =>[orig_patent_app_number] => 11115989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793608 [patent_doc_number] => 20060014289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells' [patent_app_type] => utility [patent_app_number] => 11/107371 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9500 [patent_no_of_claims] => 115 [patent_no_of_ind_claims] => 99 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014289.pdf [firstpage_image] =>[orig_patent_app_number] => 11107371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978525 [patent_doc_number] => 20050288243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Methods and compositions for treating gain-of-function disorders using RNA interference' [patent_app_type] => utility [patent_app_number] => 11/101162 [patent_app_country] => US [patent_app_date] => 2005-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22227 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288243.pdf [firstpage_image] =>[orig_patent_app_number] => 11101162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051293 [patent_doc_number] => 20050187180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA' [patent_app_type] => utility [patent_app_number] => 11/098796 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13327 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187180.pdf [firstpage_image] =>[orig_patent_app_number] => 11098796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4535035 [patent_doc_number] => 07872117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'c-met siRNA adenovirus vectors inhibit cancer cell growth, invasion and tumorigenicity' [patent_app_type] => utility [patent_app_number] => 10/599327 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 25 [patent_no_of_words] => 15591 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872117.pdf [firstpage_image] =>[orig_patent_app_number] => 10599327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591663 [patent_doc_number] => 20060041115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Methods for preparing oligonucleotides having chiral phosphorothioate linkages' [patent_app_type] => utility [patent_app_number] => 11/081880 [patent_app_country] => US [patent_app_date] => 2005-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17140 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20060041115.pdf [firstpage_image] =>[orig_patent_app_number] => 11081880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4496183 [patent_doc_number] => 07947659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'iRNA agents targeting VEGF' [patent_app_type] => utility [patent_app_number] => 11/078073 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 51 [patent_no_of_words] => 49153 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947659.pdf [firstpage_image] =>[orig_patent_app_number] => 11078073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224434 [patent_doc_number] => 20050261249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Antisense composition and method for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/077871 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12823 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261249.pdf [firstpage_image] =>[orig_patent_app_number] => 11077871 [rel_patent_id] =>[rel_patent_doc_number] =>)